Company Overview
More
Sinopharm holding Co., Ltd. is a Chinese company mainly engaged in the distribution of drugs and medical devices. The company operates through four departments. The pharmaceutical distribution department distributes pharmaceutical products to customers such as hospitals, other distributors, retail pharmacies and clinics. The medical device business unit distributes medical devices to customers and provides installation and maintenance services. The pharmaceutical retail business department operates pharmaceutical chain stores. Other business units distribute laboratory supplies, manufacture and distribute chemical reagents, and produce and sell pharmaceutical products.
CEO： Qingming Yu
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
01099 SINOPHARM
19.080+0.620+3.36%
YOY
Do not show
(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Assets
Current assets
Inventory
11.78%
56.3B
9.37%
51.5B
6.81%
52.07B
8.85%
50.82B
Accounts receivable
13.99%
193.22B
17.93%
171.39B
15.11%
192.23B
21.84%
190.19B
Notes receivable
12.77%
3.64B
--
--
6.4%
3.05B
--
--
Insurance and other receivables-current assets
107.84%
13.5B
--
--
13.92%
6.34B
--
--
Advance deposits and other receivables
--
--
--
--
--
--
--
1.21M
Cash and equivalents
-5.9%
35.91B
-13.25%
43.53B
-16%
33.14B
-12.62%
34.36B
Financial assets at fair value-current assets
--
--
-69.98%
11.75M
--
--
-99.57%
169K
Other current assets
36.8%
1.07B
--
--
28.53%
830.28M
--
--
Special items of current assets
-97.29%
181.65M
-1.92%
24.49B
-1.04%
6.98B
8.01%
24.58B
Adjustment items of current assets
--
--
--
--
--
0.01
--
--
Total current assets
10.12%
314.61B
8.71%
290.92B
8.43%
304.34B
13.23%
299.95B
Non-current assets
Fixed assets
-0.17%
10.38B
--
--
-0.24%
10.35B
--
--
Property, plant and equipment
--
--
2.95%
12.42B
--
--
3.26%
12.06B
Investment property
-4.7%
972.31M
-7.21%
588.37M
-5.77%
1B
-7.69%
611.32M
Construction in progress
40.85%
807.7M
--
--
19.97%
688.64M
--
--
Long-term receivables
-10.53%
2.4B
--
--
-2.59%
2.59B
-14.09%
28.49M
Development expenditure
1.14%
81.95M
--
--
7.81%
87.27M
--
--
Associated company interest
--
--
8.43%
8.39B
--
--
11.07%
8.02B
Interests in Joint Venture
--
--
-23.6%
27M
--
--
-28.15%
25.74M
long-term investment
8.3%
8.61B
--
--
10.25%
8.26B
--
--
Financial assets at fair value-non-current assets
--
--
12.01%
688.56M
--
--
-10.03%
613.97M
Intangible assets
-5.05%
4.53B
-3.15%
10.39B
-1.42%
4.74B
13.15%
11.01B
Goodwill
-6.07%
7.06B
--
--
3.71%
7.51B
--
--
Deferred tax assets
12.76%
1.74B
11.58%
1.79B
9.06%
1.57B
14.44%
1.7B
Other illiquid assets
10.94%
2.72B
-4.31%
3.12B
67.65%
2.72B
2.29%
3.36B
Special items of non-current assets
6.31%
6.56B
1.83%
7.08B
5.97%
6.49B
5.26%
6.96B
Total non-current assets
1.6%
45.95B
1.98%
44.49B
5.86%
46.08B
7.15%
44.38B
Total assets
8.96%
360.56B
7.77%
335.41B
8.09%
350.42B
12.4%
344.33B
Liabilities
Current liabilities
Accounts payable
18.44%
98.26B
14.03%
128.43B
9.28%
96.33B
24.08%
121.33B
Notes payable
8.36%
32.79B
--
--
16.01%
31.45B
--
--
Tax payable
12.98%
1.9B
9.79%
1.61B
-6.04%
2.09B
9.68%
1.17B
Dividend payable
--
--
13.52%
246.21M
--
--
2.07%
2.34B
Other payables and accrued expenses
-0.67%
27.01B
1%
26.23B
8.14%
23.77B
18.27%
27.76B
Advance payment
656.86%
21.06M
--
--
--
22.29M
--
--
Short-term borrowing
15.32%
62.09B
--
--
13.48%
63.28B
--
--
Other loans-current liabilities
--
--
0.35%
55.15B
--
--
-5.18%
71.83B
Financial lease liabilities-current liabilities
--
--
10.09%
1.55B
--
--
20.38%
1.36B
Other current liabilities
-46.04%
5.17B
--
--
-61.24%
4.56B
--
--
Special items of current liabilities
37.48%
8.79B
-16.9%
6.09B
42.99%
6.53B
-8.87%
6.54B
Total current liabilities
10.01%
242.15B
7.52%
219.31B
7.04%
235.15B
11.33%
232.32B
Net current assets
10.5%
72.47B
12.54%
71.62B
13.45%
69.19B
20.24%
67.64B
Total assets less current liabilities
6.86%
118.41B
8.25%
116.11B
10.29%
115.27B
14.69%
112.01B
Non-current liabilities
Long-term bank loan
14.35%
1.81B
--
--
119.69%
1.92B
--
--
Other loans-non-current liabilities
--
--
-5.61%
8.42B
--
--
28.28%
10.32B
Long-term accounts payable
-36.46%
189.4M
--
--
-33.41%
368.08M
--
--
Long-term remuneration payable to staff and workers
-6.24%
87.23M
-2.2%
387.7M
12.16%
94.79M
-0.08%
393.56M
Financial lease liabilities-non-current liabilities
--
--
0.21%
3.25B
--
--
-0.73%
3.28B
Deferred tax liability
-4.67%
1.01B
-8%
1.02B
-5.64%
1.02B
-0.17%
1.07B
Deferred income-non-current liabilities
-2.17%
394.87M
--
--
1.53%
398.9M
--
--
Issued debt instrument
-23.01%
6.69B
--
--
-13.09%
8.68B
--
--
Other non-current liabilities
-11.06%
2.58B
-7.65%
3.32B
71.61%
2.83B
78.81%
3.71B
Special items of non-current liabilities
-0.64%
3.39B
10.28%
56.75M
-0.07%
3.58B
-9.74%
62.24M
Total non-current liabilities
-12.41%
16.14B
-4.97%
16.45B
3.77%
18.9B
25.9%
18.84B
Total liabilities
8.28%
258.29B
6.54%
235.76B
6.79%
254.05B
12.31%
251.15B
Total assets less total liabilities
10.71%
102.27B
10.79%
99.65B
11.67%
96.37B
12.66%
93.18B
Total equity and non-current liabilities
6.86%
118.41B
8.25%
116.11B
10.29%
115.27B
14.69%
112.01B
Equity
Share capital
0%
3.12B
0%
3.12B
0%
3.12B
0%
3.12B
Reserve
--
--
10.38%
58.77B
--
--
11.79%
54.67B
Legal reserve
18.23%
1.79B
10.38%
58.77B
18.52%
1.51B
11.79%
54.67B
Capital reserve
-0.34%
20.43B
--
--
-0.23%
20.4B
--
--
Undistributed profit
16.98%
38.13B
--
--
18.92%
34.93B
--
--
Special items of shareholders' rights and interests
43.29%
11.84M
0%
-3.84M
37.63%
9.15M
93.49%
-3.84M
Shareholders' Equity
9.95%
63.47B
9.81%
61.89B
10.6%
59.96B
11.2%
57.79B
Non-controlling interest
11.97%
38.8B
12.44%
37.77B
13.46%
36.41B
15.14%
35.39B
Total equity
10.71%
102.27B
10.79%
99.65B
11.67%
96.37B
12.66%
93.18B
Total equity and total liabilities
8.96%
360.56B
7.77%
335.41B
8.09%
350.42B
12.4%
344.33B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)HKASCAS (2007)HKAS
Audit Opinions
--Unqualified Opinion----
Auditor
--Ernst & Young accounting firm (special general partnership), Ernst & Young accounting firm----
Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%